Chronic kidney disease (CKD) is a clinical condition characterized by high morbidity and mortality. Globally, CKD is also increasing in prevalence and incidence. The two principal kidney measures namely estimated glomerular filtration rate (eGFR) and albuminuria have been found to be predictors of renal and cardiovascular (CV) endpoints including peripheral artery disease (PAD). The prevalence of PAD was increased in CKD patients and, particularly, in patients with more severe CKD stages. Despite the fact that revascularization strategies are suitable in CKD patients in similar fashion to non-CKD patients, few CKD patients underwent these procedures. In fact, if it is true that revascularization improves prognosis in PAD patients irrespective of baseline eGFR, it was also demonstrated that CKD patients, who underwent revascularization, were at higher risk for amputations, mortality, re-intervention and perioperative complications. With the present review article, we have examined the association between CKD, PAD and peripheral revascularization highlighting data about epidemiology, pathophysiologic mechanisms, and results from previous observational and intervention studies. We have also examined the future perspectives and challenges of research around the association between CKD and PAD.

The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization / Serra, Raffaele; Bracale, Umberto Marcello; Ielapi, Nicola; Del Guercio, Luca; Di Taranto, Maria Donata; Sodo, Maurizio; Michael, Ashour; Faga, Teresa; Bevacqua, Egidio; Jiritano, Federica; Serraino, Giuseppe Fliberto; Mastroroberto, Pasquale; Provenzano, Michele; Andreucci, Michele. - In: INTERNATIONAL JOURNAL OF GENERAL MEDICINE. - ISSN 1178-7074. - Volume 14:(2021), pp. 3749-3759. [10.2147/IJGM.S322417]

The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization

Ielapi, Nicola;
2021

Abstract

Chronic kidney disease (CKD) is a clinical condition characterized by high morbidity and mortality. Globally, CKD is also increasing in prevalence and incidence. The two principal kidney measures namely estimated glomerular filtration rate (eGFR) and albuminuria have been found to be predictors of renal and cardiovascular (CV) endpoints including peripheral artery disease (PAD). The prevalence of PAD was increased in CKD patients and, particularly, in patients with more severe CKD stages. Despite the fact that revascularization strategies are suitable in CKD patients in similar fashion to non-CKD patients, few CKD patients underwent these procedures. In fact, if it is true that revascularization improves prognosis in PAD patients irrespective of baseline eGFR, it was also demonstrated that CKD patients, who underwent revascularization, were at higher risk for amputations, mortality, re-intervention and perioperative complications. With the present review article, we have examined the association between CKD, PAD and peripheral revascularization highlighting data about epidemiology, pathophysiologic mechanisms, and results from previous observational and intervention studies. We have also examined the future perspectives and challenges of research around the association between CKD and PAD.
2021
chronic kidney disease; CKD; peripheral artery disease; PAD; ESKD; amputations; albuminuria
01 Pubblicazione su rivista::01a Articolo in rivista
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization / Serra, Raffaele; Bracale, Umberto Marcello; Ielapi, Nicola; Del Guercio, Luca; Di Taranto, Maria Donata; Sodo, Maurizio; Michael, Ashour; Faga, Teresa; Bevacqua, Egidio; Jiritano, Federica; Serraino, Giuseppe Fliberto; Mastroroberto, Pasquale; Provenzano, Michele; Andreucci, Michele. - In: INTERNATIONAL JOURNAL OF GENERAL MEDICINE. - ISSN 1178-7074. - Volume 14:(2021), pp. 3749-3759. [10.2147/IJGM.S322417]
File allegati a questo prodotto
File Dimensione Formato  
Serra_Impact_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.15 MB
Formato Adobe PDF
1.15 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1563220
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 15
  • ???jsp.display-item.citation.isi??? 13
social impact